Target intelligence / Profile preview

Cytochrome c pseudogene 29 (CYCSP29)

Target: CYCSP29
Molecular classification: Other (Pseudogene)

Overview

CYCS pseudogene 29 (CYCSP29), also known as HCP29, is a non-coding genomic sequence in humans that arose as a non-functional copy (pseudogene) of the functional cytochrome c, somatic gene (CYCS)[4][5][3]. Like the majority of cytochrome c pseudogenes, it contains sequence disruptions and lacks both introns and expression evidence, indicating it does not produce a functional protein[3]. There is no evidence that CYCSP29 is expressed or has direct biological or pathological roles in humans. It is not a therapeutic target and has no known relevance for drug development or disease functions[5].

Other names: HCP29CYCS pseudogene 29

Beyond the preview

Go deeper on Cytochrome c pseudogene 29 (CYCSP29).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome c pseudogene 29 (CYCSP29).

Explore the full profile